We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+8.7%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$189B
AUM Growth
-$6.65B
(-3.4%)
Cap. Flow
-$21B
Cap. Flow
% of AUM
-11.12%
Top 10 Holdings %
Top 10 Hldgs %
16.9%
Holding
4,784
New
635
Increased
1,494
Reduced
2,137
Closed
388
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$826M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$813M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$305M |
| 4 |
Microsoft
MSFT
|
+$261M |
| 5 |
Pinterest
PINS
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.27B |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$1.08B |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$1.02B |
| 4 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$843M |
| 5 |
Linde
LIN
|
+$803M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.66% |
| 2 | Healthcare | 11.06% |
| 3 | Financials | 8.17% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Communication Services | 6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HERA
3376
DELISTED
FTAC Hera Acquisition Corp. Class A Ordinary Shares
HERA
| $887K | ﹤0.01% |
+90,953
| New | +$889K |
|
3377
Celldex Therapeutics
CLDX
$3.22B
| $883K | ﹤0.01% |
26,422
-22,532
| -46% | -$618K |
|
|
HMHC
3378
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $882K | ﹤0.01% |
79,937
-59,889
| -43% | -$564K |
|
3379
Anika Therapeutics
ANIK
$257M
| $880K | ﹤0.01% |
20,313
+1,013
| +5% | +$43.1K |
|
3380
BJ's Restaurants
BJRI
$1.44B
| $880K | ﹤0.01% |
17,910
-3,894
| -18% | -$215K |
|
3381
Castle Biosciences
CSTL
$929M
| $879K | ﹤0.01% |
11,995
-589
| -5% | -$38.9K |
|
3382
Nelnet
NNI
$4.88B
| $875K | ﹤0.01% |
11,512
-1,663
| -13% | -$125K |
|
3383
CALL
Best Buy
BBY
$17.8B
| $874K | ﹤0.01% |
+7,600
| New | +$887K |
|
3384
Argan
AGX
$8.44B
| $873K | ﹤0.01% |
18,433
-982
| -5% | -$48.9K |
|
3385
Perdoceo Education
PRDO
$2.07B
| $872K | ﹤0.01% |
71,025
-14,648
| -17% | -$179K |
|
3386
CEVA Inc
CEVA
$954M
| $871K | ﹤0.01% |
18,427
+43
| +0.2% | +$2.12K |
|
3387
MGP Ingredients
MGPI
$379M
| $871K | ﹤0.01% |
12,871
-634
| -5% | -$41.5K |
|
3388
Revolution Medicines
RVMD
$41.9B
| $869K | ﹤0.01% |
27,382
+11,641
| +74% | +$406K |
|
3389
CALL
Zillow
Z
$8.26B
| $868K | ﹤0.01% |
7,100
-91,300
| -93% | -$11.1M |
|
3390
Columbus McKinnon
CMCO
$620M
| $867K | ﹤0.01% |
17,986
-5,825
| -24% | -$298K |
|
3391
Chefs' Warehouse
CHEF
$4.43B
| $866K | ﹤0.01% |
27,223
-3,881
| -12% | -$124K |
|
3392
Karyopharm Therapeutics
KPTI
$43.3M
| $866K | ﹤0.01% |
5,598
-393
| -7% | -$57K |
|
|
MCFE
3393
DELISTED
McAfee Corp. Class A Common Stock
MCFE
| $866K | ﹤0.01% |
+30,925
| New | +$792K |
|
3394
PUT
Vornado Realty Trust
VNO
$7.51B
| $865K | ﹤0.01% |
+18,600
| New | +$870K |
|
3395
Super Micro Computer
SMCI
$19.6B
| $864K | ﹤0.01% |
245,780
-46,810
| -16% | -$172K |
|
|
EMBJ
3396
Embraer S.A. ADS
EMBJ
$13B
| $862K | ﹤0.01% |
57,385
-6,656
| -10% | -$86K |
|
|
FTCH
3397
CALL
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $862K | ﹤0.01% |
16,800
+8,600
| +105% | +$408K |
|
3398
REX American Resources
REX
$1.45B
| $861K | ﹤0.01% |
55,782
+5,406
| +11% | +$78.6K |
|
3399
California Resources
CRC
$4.56B
| $860K | ﹤0.01% |
+29,338
| New | +$807K |
|
3400
Globalstar
GSAT
$10.7B
| $858K | ﹤0.01% |
32,119
-9,945
| -24% | -$195K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q2 2021 Portfolio in Review
As of Q2 2021, Credit Suisse held 4,784 positions worth $189B, down 3.4% from $195B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse withdrew a net $21B in Q2 2021, closing 388 positions and reducing 2,137 holdings. Its most notable exit was INPHI CORPORATION, an estimated $356M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Credit Suisse opened a new position in Recursion Pharmaceuticals worth $52.9M.
- Credit Suisse's largest Q2 2021 buy was Recursion Pharmaceuticals: 1,449,585 shares worth $52.9M.
- Credit Suisse added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $826M increase.
- Credit Suisse's biggest Q2 2021 reduction was Alibaba, cutting an estimated $1.27B.
- Credit Suisse fully exited INPHI CORPORATION in Q2 2021, selling an estimated $356M.
- Credit Suisse's ten largest holdings make up 17% of its $189B portfolio in Q2 2021.
- Credit Suisse opened 635 new positions and closed 388 in Q2 2021.
- Credit Suisse's portfolio value fell 3.4% quarter-over-quarter to $189B.
Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.